Mapping large numbers of results may take a few moments.
Search Results
Showing 401 - 414 of 414 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh |
| |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing technologies to produce large quantities of hepatocytes (liver cells) on demand for cell therapy, regenerative medicine and pharmaceutical applications. | Location Charlotte |
| |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |
| |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |
| |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park |
| |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |
| |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh |
| |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park |
| |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |
| |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |